Guillain-Barre syndrome due to combination use of sunitinib and pembrolizumab

Yuan Wei, Li Yunjing, Xu Ping, Liu Wenhui

PDF(260 KB)
PDF(260 KB)
Adverse Drug Reactions Journal ›› 2020, Vol. 22 ›› Issue (8) : 477-478. DOI: 10.3760/cma.j.cn114015-20190305-00207

Guillain-Barre syndrome due to combination use of sunitinib and pembrolizumab

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2020, 22(8): 477-478 https://doi.org/10.3760/cma.j.cn114015-20190305-00207

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(260 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉